Silverfin false false 31/03/2025 01/04/2024 31/03/2025 S Maiden R Maiden 10 July 2025 no description of principal activity 08359790 2025-03-31 08359790 2024-03-31 08359790 core:CurrentFinancialInstruments 2025-03-31 08359790 core:CurrentFinancialInstruments 2024-03-31 08359790 core:ShareCapital 2025-03-31 08359790 core:ShareCapital 2024-03-31 08359790 core:RetainedEarningsAccumulatedLosses 2025-03-31 08359790 core:RetainedEarningsAccumulatedLosses 2024-03-31 08359790 core:PlantMachinery 2024-03-31 08359790 core:Vehicles 2024-03-31 08359790 core:FurnitureFittings 2024-03-31 08359790 core:OfficeEquipment 2024-03-31 08359790 core:PlantMachinery 2025-03-31 08359790 core:Vehicles 2025-03-31 08359790 core:FurnitureFittings 2025-03-31 08359790 core:OfficeEquipment 2025-03-31 08359790 2023-03-31 08359790 core:AcceleratedTaxDepreciationDeferredTax 2025-03-31 08359790 core:AcceleratedTaxDepreciationDeferredTax 2024-03-31 08359790 2024-04-01 2025-03-31 08359790 bus:FilletedAccounts 2024-04-01 2025-03-31 08359790 bus:SmallEntities 2024-04-01 2025-03-31 08359790 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 08359790 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 08359790 bus:Director1 2024-04-01 2025-03-31 08359790 bus:Director2 2024-04-01 2025-03-31 08359790 core:PlantMachinery core:TopRangeValue 2024-04-01 2025-03-31 08359790 core:Vehicles core:TopRangeValue 2024-04-01 2025-03-31 08359790 core:FurnitureFittings 2024-04-01 2025-03-31 08359790 core:OfficeEquipment core:TopRangeValue 2024-04-01 2025-03-31 08359790 2023-04-01 2024-03-31 08359790 core:PlantMachinery 2024-04-01 2025-03-31 08359790 core:Vehicles 2024-04-01 2025-03-31 08359790 core:OfficeEquipment 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: 08359790 (England and Wales)

CHAMELEON CONSULTING (HEALTHCARE) LIMITED

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH THE REGISTRAR

CHAMELEON CONSULTING (HEALTHCARE) LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025

Contents

CHAMELEON CONSULTING (HEALTHCARE) LIMITED

COMPANY INFORMATION

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
CHAMELEON CONSULTING (HEALTHCARE) LIMITED

COMPANY INFORMATION (continued)

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
DIRECTORS S Maiden
R Maiden
REGISTERED OFFICE Wey Court West
Union Road
Farnham
Surrey
GU9 7PT
United Kingdom
COMPANY NUMBER 08359790 (England and Wales)
ACCOUNTANT Shaw Gibbs Limited
Wey Court West
Union Road
Farnham
Surrey
GU9 7PT
CHAMELEON CONSULTING (HEALTHCARE) LIMITED

STATEMENT OF FINANCIAL POSITION

AS AT 31 MARCH 2025
CHAMELEON CONSULTING (HEALTHCARE) LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

AS AT 31 MARCH 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 42,675 61,429
42,675 61,429
Current assets
Debtors 4 205,907 140,736
Cash at bank and in hand 5 60,650 179,982
266,557 320,718
Creditors: amounts falling due within one year 6 ( 34,610) ( 80,942)
Net current assets 231,947 239,776
Total assets less current liabilities 274,622 301,205
Provision for liabilities 7 ( 14,220) ( 15,357)
Net assets 260,402 285,848
Capital and reserves
Called-up share capital 100 100
Profit and loss account 260,302 285,748
Total shareholders' funds 260,402 285,848

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Chameleon Consulting (Healthcare) Limited (registered number: 08359790) were approved and authorised for issue by the Board of Directors on 10 July 2025. They were signed on its behalf by:

R Maiden
Director
CHAMELEON CONSULTING (HEALTHCARE) LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
CHAMELEON CONSULTING (HEALTHCARE) LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Chameleon Consulting (Healthcare) Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Wey Court West, Union Road, Farnham, Surrey, GU9 7PT, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Statement of Income and Retained Earnings in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Statement of Financial Position.

Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery 10 years straight line
Vehicles 5 years straight line
Fixtures and fittings 25 % reducing balance
Office equipment 3 years straight line

Depreciation methods, useful lives and residual values are reviewed at each balance sheet date. The selection of these residual values and estimated lives requires the exercise of judgement. The directors are required to assess whether there is an indication of impairment to the carrying value of assets. In making that assessment, judgements are made in estimating value in use. The directors consider that the individual carrying values of assets are supportable by their value in use.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Provisions

Provisions are recognised when the has a present obligation (legal or constructive) as a result of a past event, it is probable that the will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Statement of Financial Position date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 3 3

3. Tangible assets

Plant and machinery Vehicles Fixtures and fittings Office equipment Total
£ £ £ £ £
Cost
At 01 April 2024 19,287 94,710 5,955 28,911 148,863
Additions 0 0 0 3,282 3,282
At 31 March 2025 19,287 94,710 5,955 32,193 152,145
Accumulated depreciation
At 01 April 2024 19,287 37,884 5,271 24,992 87,434
Charge for the financial year 0 18,942 171 2,923 22,036
At 31 March 2025 19,287 56,826 5,442 27,915 109,470
Net book value
At 31 March 2025 0 37,884 513 4,278 42,675
At 31 March 2024 0 56,826 684 3,919 61,429

4. Debtors

2025 2024
£ £
Trade debtors 0 8,480
Prepayments 907 1,369
VAT recoverable 0 887
Other debtors 205,000 130,000
205,907 140,736

5. Cash and cash equivalents

2025 2024
£ £
Cash at bank and in hand 60,650 179,982

6. Creditors: amounts falling due within one year

2025 2024
£ £
Accruals 2,250 2,250
Taxation and social security 28,215 56,420
Other creditors 4,145 22,272
34,610 80,942

7. Deferred tax

2025 2024
£ £
At the beginning of financial year ( 15,357) ( 19,995)
Credited to the Statement of Income and Retained Earnings 1,137 4,638
At the end of financial year ( 14,220) ( 15,357)

The deferred taxation balance is made up as follows:

2025 2024
£ £
Accelerated capital allowances ( 14,220) ( 15,357)